Evening Market Wrap

Evening Market Wrap Friday, October 21, 2011, 17:01 Contents Commentary Corporate News Commentary Optimism About European Summits Leads To Rally On Wall Street - U.S. Commentary With traders expressing optimism about the outcome of the upcoming summits of European leaders, stocks saw considerable strength during trading on Friday. The markets also benefited from a positive reaction to the latest batch of earnings news. (Oct 21, 2011) Full Article Corporate News Merck Returns Parkinson's Disease Drug Rights To Newron German pharma company Merck KgaA reported Friday that it has decided to return all rights for safinamide, a drug candidate against Parkinson's Disease or PD, to Italy-based bio-pharma company Newron Pharmaceuticals S.p.A. The agreement termination will become effective in April 2012 and result in about 40 million euros of additional costs for the Merck Serono division in the fourth quarter, but will be excluded from both the division's and the Group's underlying core operating result for the related quarter, the company noted. (Oct 21, 2011) Full Article GE Q3 Net Profit Up General Electric Co.'s (GE) third-quarter 2011 operating earnings were $3.4 billion, up 11% from $3.1 billion in the previous year. Including the effects of discontinued operations, third-quarter net earnings attributable to GE were $3.22 billion in 2011 compared with $2.1 billion in the third quarter of 2010, a 57% growth. (Oct 21, 2011) Full Article Verizon Q3 Profit Grows Verizon Communications Inc.'s (VZ) third-quarter net income advanced 31.3% to $3.54 billion from last year's $2.70 billion. Net income attributable to Verizon amounted to $1.38 billion compared with $659 million a year earlier. Quarterly earnings per share were $0.49, significantly higher than $0.23 in the prior-year quarter. (Oct 21, 2011) Full Article Home | Top Stories | Breaking News | Economic News | Forex | Politics | Featured Interviews Sent to autoforextradingpro@gmail.com | Customize your alerts | Unsubscribe Copyright © 2011 RTTNews. All rights reserved. By using this service, you agree to the Terms of Service